L. de Marinis

发表

Proteomic approach in the identification of fertility pattern in seminal plasma of fertile men.

I. Messana, M. Castagnola, A. Pontecorvi, 2012, Fertility and sterility.

Italian Association of Clinical Endocrinologists (AME) and Italian AACE Chapter Position Statement for Clinical Practice: Acromegaly - Part 2: Therapeutic Issues

P. Chanson, V. Toscano, F. Logoluso, 2020, Endocrine, metabolic & immune disorders drug targets.

Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study

A. Colao, L. Naves, P. Freda, 2014, Pituitary.

Somatotropic Axis in Human Aging

A. Giampietro, S. Chiloiro, L. de Marinis, 2019, Encyclopedia of Endocrine Diseases.

Hypopituitarism and growth hormone deficiency (GHD) after traumatic brain injury (TBI).

S. Grottoli, E. Ghigo, M. Gasperi, 2004, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury

S. Cannavò, E. Ghigo, S. Benvenga, 2004, Clinical endocrinology.

Corticotropin-releasing hormone inhibition of gonadotropin release and the effect of opioid blockade.

S. Corsello, S. Casa, L. Marinis, 1989, The Journal of clinical endocrinology and metabolism.

Galectin-3 and Estrogen Receptor Alpha as Prognostic Markers in Prolactinoma: Preliminary Results From a Pilot Study

A. Pontecorvi, A. Bianchi, A. Giampietro, 2021, Frontiers in Endocrinology.

Paradoxical growth hormone response to thyrotropin-releasing hormone in acromegaly. Clinical correlations and prognostic value.

G. Maira, C. Anile, L. de Marinis, 1990, Acta endocrinologica.

Use of Pegvisomant in acromegaly. An Italian Society of Endocrinology guideline

E. Menis, S. Cannavò, S. Grottoli, 2014, Journal of Endocrinological Investigation.

Empty sella syndrome: Multiple endocrine disorders.

A. Bianchi, A. Giampietro, S. Chiloiro, 2021, Handbook of clinical neurology.

DIAGNOSIS OF ENDOCRINE DISEASE: Primary empty sella: a comprehensive review.

A. Bianchi, A. Giampietro, L. Marinis, 2017, European journal of endocrinology.

Calcium antagonists and hormone release. I. Effects of verapamil on insulin release in normal subjects and patients with islet-cell tumor.

L. Marinis, L. de Marinis, A. Barbarino, 1980, Metabolism: clinical and experimental.

Microalbuminuria in insulin sensitivity in patients with growth hormone-secreting pituitary tumor.

S. Grottoli, A. Pontecorvi, A. Colao, 2008, The Journal of clinical endocrinology and metabolism.

Biphasic effect of estradiol on luteinizing hormone response to gonadotropin-releasing hormone in castrated men.

L. de Marinis, A. Mancini, A. Barbarino, 1982, Metabolism: clinical and experimental.

Calcium antagonists and hormone release. II. Effects of verapamil on basal, gonadotropin-releasing hormone- and thyrotropin-releasing hormone-induced pituitary hormone release in normal subjects.

L. de Marinis, A. Barbarino, L. De Marinis, 1980, The Journal of clinical endocrinology and metabolism.

Occurrence of pituitary dysfunction following traumatic brain injury.

M. Farneti, A. Bianchi, M. Bondanelli, 2004, Journal of neurotrauma.

Association between l-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism.

A. Bianchi, A. Giampietro, L. Marinis, 2014, European journal of endocrinology.

Pancreatic metastases from a bronchopulmonary carcinoid diagnosed by endoscopic ultrasonography-guided fine-needle tissue acquisition.

G. Costamagna, A. Larghi, F. Lugli, 2012, Pancreas.

Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant

A. Pontecorvi, M. Fleseriu, A. Bianchi, 2021, Endocrine.

Plasma leptin levels after biliopancreatic diversion: dissociation with body mass index.

A. Bianchi, D. Milardi, A. Lanzone, 1999, The Journal of clinical endocrinology and metabolism.

Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency.

A. Bianchi, A. Giampietro, G. Mazziotti, 2010, European journal of endocrinology.

Acromegaly is associated with increased cancer risk: a survey in Italy.

S. Cannavò, A. Peri, S. Grottoli, 2017, Endocrine-related cancer.

Acromegalic cardiomyopathy. Left ventricular filling and hypertrophy in active and surgically treated disease.

A. Lombardo, L. de Marinis, F. Loperfido, 1992, Chest.

Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome.

A. Lanzone, A. Caruso, A. Fulghesu, 1999, Fertility and sterility.

Evaluation of antioxidant systems (coenzyme Q10 and total antioxidant capacity) in morbid obesity before and after biliopancreatic diversion.

R. Tacchino, A. Pontecorvi, G. Littarru, 2008, Metabolism: clinical and experimental.

Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool

V. Hasenmajer, M. Minnetti, A. Isidori, 2022, medRxiv.

Prognostic factors in ectopic Cushing's syndrome due to neuroendocrine tumors: a multicenter study.

G. Arnaldi, S. Cingarlini, M. Davi’, 2017, European journal of endocrinology.

Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.

A. Bianchi, A. Giampietro, L. Marinis, 2004, The Journal of clinical endocrinology and metabolism.

Opioid dysregulation after biliopancreatic diversion: effect of naloxone on preprandial and postprandial growth hormone (GH)-releasing hormone-induced GH release in surgically induced weight loss.

A. Bianchi, D. Milardi, A. Giampietro, 2001, Metabolism: clinical and experimental.

Effects of testosterone on antioxidant systems in male secondary hypogonadism.

G. Maira, A. Pontecorvi, G. Littarru, 2008, Journal of andrology.

Coenzyme Q10 evaluation in pituitary‐adrenal axis disease: Preliminary data

A. Bianchi, A. Giampietro, F. Principi, 2005, BioFactors.

Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.

G. Maira, A. Pontecorvi, A. Bianchi, 2007, Endocrine-related cancer.

Growth hormone response to propranolol and L--dopa in obese subjects.

L. de Marinis, A. Barbarine, L. Troncone, 1978, Metabolism: clinical and experimental.

Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa.

A. Tofani, L. de Marinis, A. Mancini, 1988, The Journal of clinical endocrinology and metabolism.

Effect of the opioid blockade on the feeding-induced growth hormone response to growth hormone-releasing hormone in women with polycystic ovary syndrome.

A. Lanzone, A. Barini, M. Guido, 2002, Fertility and sterility.

Effect of feeding on growth hormone response to growth hormone-releasing hormone in polycystic ovarian syndrome: relation with body weight and hyperinsulinism.

A. Lanzone, L. Soranna, S. Mancuso, 2001, Human reproduction.

[Hyperandrogenism originating from the adrenal gland. Current observations on a clinical case].

E. Moneta, L. de Marinis, A. Mancini, 1989, Minerva ginecologica.

Seminal antioxidant capacity in pre- and postoperative varicocele.

A. Bianchi, D. Milardi, E. Meucci, 2004, Journal of andrology.

Total antioxidant capacity in patients with varicoceles.

D. Milardi, E. Meucci, G. Martorana, 2003, Fertility and sterility.

Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin.

A. Lanzone, M. Giuliani, M. Guido, 2007, Fertility and sterility.

Effects of high-dose octreotide LAR on glucose metabolism in patients with acromegaly inadequately controlled by conventional somatostatin analog therapy.

S. Cannavò, S. Grottoli, F. Bogazzi, 2011, European journal of endocrinology.

Normal pituitary function and reserve after selective transsphenoidal removal of a thyrotropin-producing pituitary adenoma.

G. Maira, C. Anile, L. de Marinis, 1980, Metabolism: clinical and experimental.

Circulating endothelial cells as marker of endothelial damage in male hypogonadism.

A. Pontecorvi, D. Milardi, A. Giampietro, 2012, Journal of andrology.

Impact of long-term naltrexone treatment on growth hormone and insulin secretion in hyperandrogenic and normal obese patients.

L. Marinis, A. Lanzone, A. Caruso, 1997, Metabolism: clinical and experimental.

Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study.

G. Maira, M. Korbonits, A. Pontecorvi, 2016, European journal of endocrinology.

Nonalcoholic fatty liver disease is associated with increased GHBP and reduced GH/IGF‐I levels

A. Bianchi, A. Giampietro, L. Riccardi, 2012, Clinical endocrinology.

Serum prolactin response to thyrotropin-releasing hormone and metoclopramide in patients with prolactin-secreting tumors before and after transsphenoidal surgery.

G. Maira, C. Anile, L. de Marinis, 1978, The Journal of clinical endocrinology and metabolism.

Residual pituitary function after brain injury-induced hypopituitarism: a prospective 12-month study.

S. Cannavò, E. Ghigo, S. Benvenga, 2005, The Journal of clinical endocrinology and metabolism.

Provocative hypothalamopituitary axis tests in severe head injury: correlations with severity and prognosis.

F. Della Corte, V. Mignani, L. de Marinis, 1998, Critical care medicine.

Understanding the effect of acromegaly on the human skeleton

A. Bianchi, A. Giampietro, S. Chiloiro, 2016, Expert review of endocrinology & metabolism.

Active acromegaly enhances spontaneous parathyroid hormone pulsatility.

J. Veldhuis, G. Mazziotti, E. de Menis, 2006, Metabolism: clinical and experimental.

Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.

G. Maira, A. Bianchi, A. Giampietro, 2002, Metabolism: clinical and experimental.

Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism.

A. Lanzone, V. Pavone, S. Mancuso, 1999, Fertility and sterility.

Predictors of morbidity and mortality in acromegaly: an Italian survey.

S. Cannavò, A. Peri, S. Grottoli, 2012, European journal of endocrinology.

Treatment of Acromegalic Osteopathy in Real-Life Clinical Practice: The BAAC (Bone Active drugs in ACromegaly) Study.

S. Grottoli, E. Ghigo, I. Chiodini, 2020, The Journal of clinical endocrinology and metabolism.

Pasireotide for acromegaly: long-term outcomes from an extension to the Phase III PAOLA study

M. Fleseriu, I. Shimon, M. Gadelha, 2020, European journal of endocrinology.

Pegvisomant in acromegaly: an update

E. Menis, G. Arnaldi, S. Cannavò, 2017, Journal of Endocrinological Investigation.

High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial.

S. Cannavò, E. Ghigo, F. Bogazzi, 2009, European journal of endocrinology.

Influence of growth hormone receptor d3 and full-length isoforms on biochemical treatment outcomes in acromegaly.

A. Pontecorvi, R. Pola, A. Bianchi, 2009, The Journal of clinical endocrinology and metabolism.

Prognostic significance of the Ki-67 labeling index in growth hormone-secreting pituitary adenomas.

G. Maira, A. Pontecorvi, A. Bianchi, 2008, The Journal of clinical endocrinology and metabolism.

Role of food intake in the modulation of hexarelin-induced growth hormone release in normal human subjects.

A. Bianchi, A. Giampietro, R. Gentilella, 2000, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Partial response to first generation SSA guides the choice and predict the outcome of second line therapy in acromegaly

A. Pontecorvi, A. Isidori, A. Bianchi, 2022, Endocrine.

Natural history of TFR2‐related hereditary hemochromatosis in a 47‐yr‐old Italian patient

M. Castori, P. Grammatico, S. Majore, 2009, European journal of haematology.

Bone safety of dual-release hydrocortisone in patients with hypopituitarism

A. Giampietro, G. Mazziotti, S. Chiloiro, 2018, Endocrine.

Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction

G. Niccoli, F. Crea, A. Pontecorvi, 2015, European journal of preventive cardiology.

Markers of humoral and cell-mediated immune response in primary autoimmune hypophysitis: a pilot study

A. Pontecorvi, A. Bianchi, A. Giampietro, 2021, Endocrine.

Prevalence and early diagnosis of coeliac disease in autoimmune thyroid disorders.

A. Tursi, G. Gasbarrini, A. Papa, 1999, Italian journal of gastroenterology and hepatology.

High Prevalence of Hyperplastic Colonic Polyps in Acromegalic Subjects

A. Pontecorvi, A. Bianchi, G. Gasbarrini, 2004, Digestive Diseases and Sciences.

ACTH-dependent Cushing syndrome: The potential benefits of simultaneous bilateral posterior retroperitoneoscopic adrenalectomy.

A. Pontecorvi, C. Lombardi, M. Raffaelli, 2011, Surgery.

Impact of the diagnostic delay of acromegaly on bone health: data from a real life and long term follow-up experience

A. Pontecorvi, A. Giampietro, S. Chiloiro, 2022, Pituitary.

Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.

S. Asa, F. Ranelletti, G. Fadda, 2016, European journal of endocrinology.

Alteration of ghrelin–neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism

A. Lanzone, G. Campagna, C. Proto, 2008, Clinical endocrinology.

Corticotropin-releasing hormone inhibition of gonadotropin secretion during the menstrual cycle.

L. Marinis, A. Tofani, S. Della Casa, 1989, Metabolism: clinical and experimental.

Growth hormone in inflammatory bowel disease.

A. Gasbarrini, A. Pontecorvi, A. Bianchi, 2006, European review for medical and pharmacological sciences.

Tumour-infiltrating cytotoxic T lymphocytes in somatotroph pituitary neuroendocrine tumours

M. Korbonits, A. Pontecorvi, D. Iacovazzo, 2019, Endocrine.

Synchronous bilateral adrenalectomy in ACTH-dependent hypercortisolism: predictors, biomarkers and outcomes

A. Pontecorvi, C. Lombardi, M. Raffaelli, 2019, Endocrine.

Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.

A. Pontecorvi, A. Bianchi, A. Giampietro, 2007, European journal of endocrinology.

Primary empty sella.

G. Maira, A. Bianchi, A. Giustina, 2005, The Journal of clinical endocrinology and metabolism.

Influence of chronic naltrexone treatment on growth hormone secretion in normal subjects.

A. Bianchi, A. Lanzone, A. Caruso, 1997, European journal of endocrinology.

Association of Graves' disease and prekallikrein congenital deficiency in a patient belonging to the first CRM+ prekallikrein-deficient Italian family.

G. Leone, V. De Stefano, L. Teofili, 1990, Thrombosis research.

Effects of galanin on growth hormone and prolactin secretion in anorexia nervosa.

A. Bianchi, D. Milardi, R. Gentilella, 2000, Metabolism: clinical and experimental.

Seminal antioxidants in humans: preoperative and postoperative evaluation of coenzyme Q10 in varicocele patients.

D. Milardi, G. Littarru, L. de Marinis, 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Relationships between intracranial pressure and diurnal prolactin secretion in primary empty sella.

G. Maira, C. Anile, B. Cioni, 1984, Neuroendocrinology.

Evaluation of dopaminergic tone in hyperprolactinemia. III. Thyroid-stimulating hormone response to metoclopramide in differential diagnosis and postoperative follow-up of prolactinoma patients.

G. Maira, C. Anile, L. de Marinis, 1985, Metabolism: clinical and experimental.